• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problems Pumping Stopped (1503); Human-Device Interface Problem (2949)
Patient Problem Dyspnea (1816)
Event Date 03/04/2017
Event Type  Injury  
Event Description
Information was received from a healthcare provider (hcp) via a clinical study regarding a patient receiving remodulin (10 mg/ml at an unknown dose) via an implantable infusion pump.It was reported a critical alarm was heard.It was noted they started hearing the alarm intermittently since (b)(6) 2017.The pump was interrogated in the clinic on (b)(6) 2017 and found to be in motor stall.The patient was admitted for replacement and peripheral remodulin.It was further reported the patient noted he heard an alarm intermittently since saturday ((b)(6) 2017) night, and thought it was a toy alarm.On monday he realized it was his pump alarming and called the coordinator.He came to the clinic, the coordinator heard the alarm right away, the pump was interrogated and found to be in a motor stall.The alarm did go off every 10 minutes in the clinic.The patient noted his only symptom was shortness of breath with exertion.He was taken to the emergency room where remodulin was started via a cadd pump through a peripheral intravenous line.The pump was decreased to minimal rate.The patient was then admitted for a pump replacement.The blood tests were all normal for the subject.The site principal investigator determined this to be related to the pump.The event was classified as serious and unanticipated adverse device effect by the investigator.The outcome of the event was reported as unresolved, further actions or treatment planned.
 
Event Description
Additional information was received from a healthcare provider via a clinical study reporting the patient was admitted to the hospital on (b)(6) 2017 and the pump was explanted 2 days later.A new pump was placed in the same pocket under twilight sedation and was set to minimal rate during the procedure.The patient had blood tests, pump interrogation, and a electrocardiography performed with all normal results.The patient was hospitalized from (b)(6) 2017.It was noted the patient's medications included benadryl iv, cefazolin iv, fentanyl iv, medazolam iv, and vancomycin iv.The patient was taken off external remodulin and the new pump was set to new a delivery dose of 40 ng/kg/min and unknown rate.The patient was discharged home after reviewing alarms on (b)(6) 2017 and the issue was reported to be resolved the same day.No further complications anticipated.
 
Manufacturer Narrative
Eval code-conclusion no longer applies.Recent fda coding changes offer limited options for medical device evaluation conclusion coding.Medtronic selected conclusion code because, although the device meets design specification, medtronic made enhancements to the design making this the closest code available with respect to this event.
 
Manufacturer Narrative
Analysis of the device found a reliability non-conformance of the pump motor with a gear train anomalies of corrosion and-or wear and-or lubrication and stall due to shaft-bearing.(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from a healthcare provider (hcp) via a clinical study indicated the patient recovered without sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer (Section G)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer Contact
lisa clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6396936
MDR Text Key69653040
Report Number3004209178-2017-05451
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 04/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/14/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/31/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-